A surge of private sector and philanthropic support has generated US$1.34 billion for the Global Fund’s Eighth Replenishment, pushing the total private sector contributions since 2022 to US$1.49 billion. This marks the largest mobilization of private funding in the Global Fund’s history, demonstrating strong commitment to advancing innovation, expanding access, and strengthening health systems for vulnerable communities worldwide. Despite economic and geopolitical uncertainty, private partners have responded with urgency, reinforcing efforts to combat AIDS, tuberculosis, and malaria.
Private funding is helping the Global Fund rapidly deploy critical tools such as lenacapavir and next-generation TB diagnostics. This accelerated support ensures that life-saving innovations reach communities quickly and equitably. Global Fund Executive Director Peter Sands emphasized the significance of this moment, describing the private sector’s actions as bold and catalytic, and calling on others to join in sustaining the momentum.
A total of 21 companies, foundations, and philanthropists contributed to this effort, shaping market pathways, improving integrated health systems, and delivering scalable solutions to at-risk populations. Major commitments include US$912 million from the Gates Foundation, US$75 million from (RED), and US$50 million from CIFF to expand TB diagnostics. Other contributors such as Anglo American, GSK, ViiV Healthcare, Goodbye Malaria, Takeda, Foundation S, and the Rockefeller Foundation strengthened support for diagnostics, community health workers, climate-related health initiatives, and resilient health systems.
New and renewed partners also provided technical and co-investment support. Companies like Roche, HELP Logistics, Siemens Healthineers, Zenysis, Orange, SC Johnson, Project Last Mile, and Johnson & Johnson committed both financial and non-financial resources to improve supply chains, enhance diagnostics, expand digital health capabilities, and strengthen prevention programs. These diverse contributions highlight a shared commitment to saving lives while preparing health systems for future challenges.
Collectively, these investments demonstrate the private sector’s critical role in driving sustainable progress and ensuring equitable access to transformative health tools. As leaders at the summit reaffirmed, the momentum must continue, with an ambitious goal of raising US$2 billion from the private sector to further accelerate global health impact.
